1. Home
  2. ABEO vs RC Comparison

ABEO vs RC Comparison

Compare ABEO & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$4.35

Market Cap

282.5M

Sector

Health Care

ML Signal

N/A

Logo Ready Capital Corproation

RC

Ready Capital Corproation

N/A

Current Price

$1.08

Market Cap

272.6M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
ABEO
RC
Founded
1974
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
282.5M
272.6M
IPO Year
2005
2011

Fundamental Metrics

Financial Performance
Metric
ABEO
RC
Price
$4.35
$1.08
Analyst Decision
Strong Buy
Hold
Analyst Count
7
7
Target Price
★ $18.88
$1.50
AVG Volume (30 Days)
1.0M
★ 1.8M
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
★ 3.48%
EPS Growth
★ 165.16
45.25
EPS
★ N/A
N/A
Revenue
★ $2,998,000.00
N/A
Revenue This Year
$804.33
N/A
Revenue Next Year
$119.68
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 258.18
N/A
52 Week Low
$4.00
$0.96
52 Week High
$7.65
$3.05

Technical Indicators

Market Signals
Indicator
ABEO
RC
Relative Strength Index (RSI) 35.92 40.35
Support Level $4.27 $1.08
Resistance Level $5.91 $1.24
Average True Range (ATR) 0.23 0.08
MACD 0.03 0.02
Stochastic Oscillator 10.83 44.10

Price Performance

Historical Comparison
ABEO
RC

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

About RC Ready Capital Corproation

Ready Capital Corp is a real estate finance company that originates, acquires, finances, and services LMM loans, SBA loans, construction loans, USDA loans and, to a lesser extent, MBS collateralized mainly by LMM loans or other real estate-related investments. Its loans are used by businesses to purchase real estate used in their operations or by investors seeking to acquire multi-family, office, retail, mixed use or warehouse properties. It operates through two segments: LMM Commercial Real Estate, which originates LMM loans across the life-cycle of an LMM property including construction, bridge, stabilized and agency loan channels, and Small Business Lending, which acquires, originates and services owner-occupied loans guaranteed by the SBA and also originates and services USDA loans.

Share on Social Networks: